Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 36,112 | 170,203 | 11,106 | 45,778 | 80,386 |
| Marketable Securities | 235,547 | 126,101 | 94,871 | 87,367 | 79,666 |
| Receivables | 56,532 | 56,841 | 5,580 | 4,390 | 5,924 |
| Inventories | 4,243 | 4,476 | 4,277 | 4,606 | 4,680 |
| TOTAL | $337,754 | $363,594 | $122,459 | $146,827 | $173,324 |
| Non-Current Assets | |||||
| PPE Net | 14,047 | 14,540 | 15,007 | 15,475 | 15,865 |
| Intangibles | 64,259 | 64,700 | 93,779 | 94,221 | 94,662 |
| Other Non-Current Assets | 1,655 | 1,754 | 1,898 | 1,993 | 285 |
| TOTAL | $79,961 | $80,994 | $110,684 | $111,689 | $110,812 |
| Total Assets | $417,715 | $444,588 | $233,143 | $258,516 | $284,136 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 11,012 | 11,289 | 1,115 | 1,115 | 1,115 |
| Accounts payable and accrued liabilities | 12,178 | 20,907 | 10,028 | 13,874 | 12,052 |
| Accrued Expenses | 42,151 | 11,511 | 9,083 | 10,800 | 21,245 |
| TOTAL | $65,341 | $44,824 | $22,469 | $28,221 | $36,751 |
| Non-Current Liabilities | |||||
| Long Term Debt | 234,171 | 233,837 | 243,953 | 243,912 | 243,887 |
| Deferred Revenues | N/A | 1,117 | 2,243 | 2,432 | 2,339 |
| Other Non-Current Liabilities | 1,102 | 1,215 | 1,325 | 1,433 | 238 |
| TOTAL | $235,273 | $235,052 | $275,560 | $275,982 | $273,790 |
| Total Liabilities | $300,614 | $279,876 | $298,029 | $304,203 | $310,541 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 106,970 | 106,272 | 106,272 | 106,272 | 106,272 |
| Common Shares | 106 | 106 | 106 | 106 | 106 |
| Retained earnings | -1,341,444 | -1,290,306 | -1,516,392 | -1,493,374 | -1,471,577 |
| Other shareholders' equity | 267 | 219 | 269 | 216 | 112 |
| TOTAL | $117,101 | $164,712 | $-64,886 | $-45,687 | $-26,405 |
| Total Liabilities And Equity | $417,715 | $444,588 | $233,143 | $258,516 | $284,136 |